In the previous decade, the prevalence of HBs-Ag positivity and the anti-HCV positivity declined in Turkey. We aimed to investigate the prevalences of HBs Ag and anti-HCV positivity in pregnant women in Ankara, the capital city of Turkey, while the vertical transmission should be important way of HBV and HCV transmission. HBs-Ag positivity was determined 2.8% (102) out of 4,700 pregnant women, and 0.1% (6) out of them were positive for anti-HCV. The prevalences of HBs Ag and anti-HCV were both similar to the rate of that seen in western region of Turkey.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00404-009-1145-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hepatitis A, B, and C in Brazilian Afro-Descendant Communities from Northeast Brazil: A Seroepidemiological Survey.
Viruses
October 2024
Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, RJ, Brazil.
Background: Viral hepatitis is a disease that is more prevalent among individuals residing in remote regions and in contexts of social vulnerability. The objective of this study was to ascertain the seroprevalence of hepatitis A (HAV), B (HBV), and C (HCV) in vulnerable communities in the rural area of São João do Piauí (SJP), northern Brazil.
Methods: Immunoenzymatic assays were employed to detect the presence of anti-HAV (total and IgM), HBsAg, anti-HBc, anti-HBs, and anti-HCV serological markers in serum samples.
Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil.
Rev Saude Publica
October 2024
Universidade Federal da Bahia. Instituto de Saúde Coletiva. Salvador, BA, Brasil.
Article Synopsis
- This study investigates viral hepatitis prevalence among young men who have sex with men (MSM) and transgender women (TGW) in three Brazilian cities, focusing on those aged 15-19.
- The research collected data through social behavioral questionnaires and blood tests to check for hepatitis A, B, and C antibodies and active infections.
- Results showed 17.7% had immunity to hepatitis A, while hepatitis B and C prevalence was lower at 2.8% and 0.2%, respectively, indicating a need for improved vaccination and treatment strategies in these populations.
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study.
Lancet Gastroenterol Hepatol
December 2024
Department of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Article Synopsis
- Chronic hepatitis B virus (HBV) is a significant global health concern, with existing treatments yielding low rates of HBsAg seroclearance; VIR-2218 (elebsiran) is being studied for its potential to reduce HBsAg levels.
- This phase 2 open-label study involved participants aged 18-65 from various countries who had chronic HBV but no cirrhosis, assessing the safety and effectiveness of VIR-2218 alone and in combination with pegylated interferon-alpha-2a.
- The study aimed to measure adverse events and clinical outcomes, including the reduction of HBsAg and long-term seroclearance rates among those receiving different treatment regimens over a period ranging from
Prevalence of hepatitis and HIV infection among 18-months old children in Guinea-Bissau before vaccination.
Trop Med Int Health
October 2024
Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Objectives: This study reports on the prevalence of hepatitis B virus (HBV) in children in Guinea-Bissau before the hepatitis B vaccine was introduced.
Methods: Cross-sectional study. From 2005 to 2008, 187 children aged 18 months were enrolled in a vaccine trial and had blood samples taken to test for HBV (HbsAg, anti-HBs and anti-HBc), hepatitis C virus (HCV) and HIV.
[Seroprevalence and Risk Factors of Hepatitis B, C and D in Adults in Trabzon, Türkiye].
Mikrobiyol Bul
July 2024
Karadeniz Technical University Faculty of Medicine, Department of Public Health, Trabzon, Türkiye.
Viral hepatitis are infections that can cause liver damage, become chronic, lead to cirrhosis, hepatocellular carcinoma and ultimately result in death due to their ability to spread in the community through blood and infected body fluids. The aim of this study was to determine the seroprevalence of hepatitis B (HBV), hepatitis C (HCV), and hepatitis D (HDV) transmitted through blood among individuals living in Trabzon province and to examine the factors potentially associated with seroprevalence. This cross-sectional study was conducted in Trabzon province, located in the northeast of Türkiye, including a total of 10 districts, including the central district.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!